ActiGraph Acquires Biofourmis Life Science Business. by Fred Pennic 01/07/2025 Leave a Comment. What You Should Know: – ActiGraph, a global leader in wearable digital health technology, announced the acquisition of Biofourmis Connect, a division of Biofourmis specializing in AI-powered digital trial platforms for the life science industry. Financial terms of the acquisition were not disclosed.– The acquisition combines ActiGraph’s expertise in wearable technology with Biofourmis Connect’s advanced analytics capabilities, creating a comprehensive and unified solution for modernizing clinical research.Acquisition ImpactThe acquisition enables ActiGraph to deliver a market-leading, device-agnostic platform that supports a wide range of clinical use cases throughout the drug development lifecycle. By integrating Biofourmis Connect’s AI-driven technology, ActiGraph enhances its ability to capture and analyze high-precision digital health data, leading to more efficient and patient-centric clinical trials.“The life science industry has sought out digital innovations to improve clinical development productivity, but they need end-to-end support solidified by operational, analytical, and regulatory expertise.  The synergies with Biofourmis Connect will allow ActiGraph to transform its portfolio by adding AI-driven analytics into a digital, device-agnostic platform, allowing our clients to benefit from a true scalable solution with a seamless experience for patients and clinical sites,” said Jeremy Wyatt, CEO of ActiGraph. “We are especially excited to welcome the seasoned Biofourmis Connect employees to our global team, strengthening our capacity for growth and innovation.”

Healthtech unicorn Biofourmis axed about 30 employees from its Singapore and India offices at the end of November, people familiar with the matter told Tech in Asia. However, the exact number of retrenched staff per country remains unclear. The move comes just a month after US-headquartered Biofourmis and General Atlantic-backed CopilotIQ announced a merger to form an AI-driven platform aimed at providing in-home healthcare. Tech in Asia has reached out to Biofourmis for comment.Photo credit: BiofourmisBiofourmis underwent two rounds of layoffs last year. The first occurred before Kuldeep Singh Rajput, the company’s CEO at the time, stepped down in August 2023. The second involved 130 employees and took place months later in October, when the firm began winding down operations in Singapore

To enhance the experience, Biofourmis is integrating with Lee Health's Epic Electronic Health Record (EHR) system, ensuring critical patient data is accessible for continuity of care and efficient management of acute and post-acute care, even from a patient's home.